AMANDA KINDEL: Open Payments
NPI 1265003792 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 76 payments from 16 companies in 2025. Trend: 2023 $268 · 2024 $625 · 2025 $1,126
Food & beverage: $1,041Education: $85
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 14 | $215 |
| UCB, Inc. | 20 | $192 |
| ABBVIE INC. | 21 | $182 |
| GENZYME CORPORATION | 5 | $147 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Amgen Inc. | 3 | $54 |
| Lilly USA, LLC | 2 | $48 |
| LEO Pharma Inc. | 1 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $27 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, SKYRIZI, RINVOQ, OTEZLA, EBGLYSS, ADBRY.
Industry payments across MS — which companies pay providers there.
